Stem Cells Get FDA Nod for Stargardt’s Disease

Advanced Cell Technology, Inc., received FDA approval for starting Phase I/II clinical trial to use stem cells for the treatment of Stargardt’s disease.  Stargardt’s disease is an inherited type of macular degeneration affecting individuals at age 10-20.  There is no cure.

Similar to other macular diseases, the photoreceptors, and the layer of cells just beneath, call the retinal pigment epithelium (RPE), become destr (Read more...)

Full Story →